Inventor · disambiguated record
David Sawutz
Also filed as: SAWUTZ DAVID · SAWUTZ DAVID G
7 granted patents·4 pending applications·39 citations·filing 1993–2019
79Inventor score
Files withSCHERING PLOUGH ANIMAL HEALTH4SCHERING CORP3STERLING WINTHROP INC2INTERVET INC1TRIZELL LTD1
Top patents by PatentIndex Score
11 records- 0189US7312248B2Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivativesSCHERING PLOUGH ANIMAL HEALTH·Filed 2005·Granted Dec 25, 2007·31 cites·17 claims
- 0271US7485650B2High affinity ligands for nociceptin receptor ORL-1SCHERING CORP·Filed 2005·Granted Feb 3, 2009·2 cites·4 claims
- 0361US7759349B2Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivativesSCHERING PLOUGH ANIMAL HEALTH·Filed 2004·Granted Jul 20, 2010·3 cites·6 claims
- 0450US7906538B2Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivativesSCHERING PLOUGH ANIMAL HEALTH·Filed 2007·Granted Mar 15, 2011·0 cites·5 claims
- 0550US2020222477A1Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive CancerTRIZELL LTD·Filed 2019·Application pending·0 cites
- 0647US7705038B2Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivativesINTERVET INC·Filed 2005·Granted Apr 27, 2010·0 cites·23 claims
- 0743US2004198704A1Compositions and method for treating microbial and parasitic infections in cattle and other animalsSCHERING CORP·Filed 2004·Application pending·0 cites
- 0842US5510380ANonpeptide bradykinin antagonistsSTERLING WINTHROP INC·Filed 1993·Granted Apr 23, 1996·2 cites·12 claims
- 0939US2006194845A1Use of ALK 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animalsSCHERING CORP·Filed 2005·Application pending·0 cites
- 1035US5578601ANonpeptide bradykinin antagonistsSTERLING WINTHROP INC·Filed 1995·Granted Nov 26, 1996·1 cites·17 claims
- 1135US2006281695A1Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivativesSCHERING PLOUGH ANIMAL HEALTH·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →